Sign inJoin waitlistJoin the waitlist

William Edenfield

Full Professor · University of South Carolina-Columbia

Credentials: · · · ·

History

University of South Carolina-Columbia
Present

Hematology and Medical Oncology
1995–1998
Internal Medicine
1992–1995
Univ of Miami Leonard M. Miller Sch of Med
1988–1992

Research

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Breast Cancer Research and Treatment · 2018 · 622 citations
Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review
Review · Journal of Clinical Oncology · 1995 · 514 citations
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b…
The Lancet Oncology · 2017 · 237 citations

JM
Julie Martin
10 papers
AF
Avery Funkhouser
7 papers · 7 as a resident
Adedayo Onitilo
3 papers
BP
Benjamin Parsons
3 papers
DA
Daniel Anderson
3 papers
Eddy Yang
3 papers
HV
Hana Vakil
3 papers
Jamil Khatri
3 papers
JS
Jennifer Slim
3 papers
JS
Jennifer Suga
3 papers
JB
John Byrd
3 papers · 2 as a fellow
Ki Chung
3 papers

Clinical trials

Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Principal investigator · Terminated · Phase 2
Prisma Health-Upstate
2016–2025
A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Principal investigator · Completed · Phase 2
Sumitomo Pharma America, Inc.
2012–2020
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
Mersana Therapeutics
2011
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Site PI · Recruiting · Phase 1, Phase 2
Nimbus Wadjet, Inc.
2025–2031